BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 26970273)

  • 21. Sphingosine-1-phosphate signaling and its role in disease.
    Maceyka M; Harikumar KB; Milstien S; Spiegel S
    Trends Cell Biol; 2012 Jan; 22(1):50-60. PubMed ID: 22001186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of macrophage function by sphingosine-1-phosphate.
    Weigert A; Weis N; Brüne B
    Immunobiology; 2009; 214(9-10):748-60. PubMed ID: 19625101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingosine kinase as a regulator of calcium entry through autocrine sphingosine 1-phosphate signaling in thyroid FRTL-5 cells.
    Gratschev D; Löf C; Heikkilä J; Björkbom A; Sukumaran P; Hinkkanen A; Slotte JP; Törnquist K
    Endocrinology; 2009 Nov; 150(11):5125-34. PubMed ID: 19797403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors.
    Orr Gandy KA; Obeid LM
    Biochim Biophys Acta; 2013 Jan; 1831(1):157-66. PubMed ID: 22801037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sphingosine kinase 1 in cancer.
    Heffernan-Stroud LA; Obeid LM
    Adv Cancer Res; 2013; 117():201-35. PubMed ID: 23290781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2.
    Adams DR; Tawati S; Berretta G; Rivas PL; Baiget J; Jiang Z; Alsfouk A; Mackay SP; Pyne NJ; Pyne S
    J Med Chem; 2019 Apr; 62(7):3658-3676. PubMed ID: 30889352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
    Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM
    Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of small-molecule inhibitors of sphingosine-1-phosphate signaling.
    Edmonds Y; Milstien S; Spiegel S
    Pharmacol Ther; 2011 Dec; 132(3):352-60. PubMed ID: 21906625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-function analysis of lipid substrates and inhibitors of sphingosine kinases.
    Adams DR; Pyne S; Pyne NJ
    Cell Signal; 2020 Dec; 76():109806. PubMed ID: 33035646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Point-counterpoint of sphingosine 1-phosphate metabolism.
    Saba JD; Hla T
    Circ Res; 2004 Apr; 94(6):724-34. PubMed ID: 15059942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune regulation by sphingosine 1-phosphate and its receptors.
    Bode C; Gräler MH
    Arch Immunol Ther Exp (Warsz); 2012 Feb; 60(1):3-12. PubMed ID: 22159476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors.
    Pyne S; Pyne N
    Pharmacol Ther; 2000 Nov; 88(2):115-31. PubMed ID: 11150592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of regulation of sphingosine kinase 1.
    Pulkoski-Gross MJ; Obeid LM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Nov; 1863(11):1413-1422. PubMed ID: 30591148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1-phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor-positive breast cancer.
    Ohotski J; Edwards J; Elsberger B; Watson C; Orange C; Mallon E; Pyne S; Pyne NJ
    Int J Cancer; 2013 Feb; 132(3):605-16. PubMed ID: 22733311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting sphingosine-1-phosphate signalling for cardioprotection.
    Kennedy S; Kane KA; Pyne NJ; Pyne S
    Curr Opin Pharmacol; 2009 Apr; 9(2):194-201. PubMed ID: 19070545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoflurane protects human kidney proximal tubule cells against necrosis via sphingosine kinase and sphingosine-1-phosphate generation.
    Kim M; Kim M; Park SW; Pitson SM; Lee HT
    Am J Nephrol; 2010; 31(4):353-62. PubMed ID: 20234131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. K6PC-5, a sphingosine kinase activator, induces anti-aging effects in intrinsically aged skin through intracellular Ca2+ signaling.
    Youm JK; Jo H; Hong JH; Shin DM; Kwon MJ; Jeong SK; Park BD; Choi EH; Lee SH
    J Dermatol Sci; 2008 Aug; 51(2):89-102. PubMed ID: 18420384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation and function of sphingosine kinase 2 in diseases.
    Song DD; Zhou JH; Sheng R
    Histol Histopathol; 2018 May; 33(5):433-445. PubMed ID: 29057430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in the role of sphingosine 1-phosphate in cancer.
    Pyne NJ; Pyne S
    FEBS Lett; 2020 Nov; 594(22):3583-3601. PubMed ID: 32969034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis.
    Ponnusamy S; Selvam SP; Mehrotra S; Kawamori T; Snider AJ; Obeid LM; Shao Y; Sabbadini R; Ogretmen B
    EMBO Mol Med; 2012 Aug; 4(8):761-75. PubMed ID: 22707406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.